{"hands_on_practices": [{"introduction": "Accurate diagnosis begins with the correct identification of the causative agent. This practice challenges you to think like a pathologist, using key ultrastructural features from a hypothetical clinical scenario to differentiate between the two most common human-pathogenic microsporidian genera. By analyzing details like host cell interaction and nuclear arrangement, you will reinforce your understanding of the fundamental biological characteristics that define *Enterocytozoon* and *Encephalitozoon* [@problem_id:4801740].", "problem": "An immunocompromised adult presents with chronic watery diarrhea. A stool concentrate stained by a modified trichrome reveals numerous oval spores with a distinct anterior dense zone and a faint posterior clear zone. Transmission Electron Microscopy (TEM) analysis of biopsied jejunal mucosa shows intracellular development of the parasite within enterocytes. Critically, the replicative stages are in direct contact with host cytoplasm and lack any surrounding host-derived membrane compartment; nuclei are observed singly (monokaryotic), and the mature spores measure approximately $1.2\\,\\mu\\text{m}$ in length with a thin endospore and an inconspicuous posterior vacuole. In a separate conjunctival scraping from another immunocompromised patient, TEM reveals intracellular organisms confined within a host-derived parasitophorous vacuole (PV), with paired nuclei (diplokaryotic) in replicative stages; mature spores measure approximately $2.0\\,\\mu\\text{m}$, have a thicker endospore, and contain a distinct posterior vacuole.\n\nStarting from the following foundational base in medical parasitology:\n\n- Microsporidia are obligate intracellular, spore-forming fungal parasites that infect host cells by everting a polar tube to inject sporoplasm directly into the host cell cytoplasm.\n- After entry, microsporidia complete merogony and sporogony either freely in the host cytoplasm or within a host-derived parasitophorous vacuole (PV). The presence or absence of a PV determines the interface with host cell resources, constraining the parasite’s developmental ultrastructure.\n- Mature microsporidian spores generally possess an exospore, an endospore, an anterior polaroplast, a coiled polar tube, and often a posterior vacuole. Nuclear arrangement during replication can be monokaryotic (single nucleus) or diplokaryotic (paired nuclei), a genus-level character.\n\nDerive a criteria set to distinguish human-pathogenic microsporidian genera using the axes of spore morphology, host cell localization, and ultrastructural features, and then situate the two clinical isolates described above—an intestinal isolate without a PV and a conjunctival isolate with a PV—into the genera Enterocytozoon and Encephalitozoon accordingly. Which option best states a correct, principle-based criterion set and correctly classifies these two isolates?\n\nA. Enterocytozoon is characterized by direct cytoplasmic development without a parasitophorous vacuole, monokaryotic nuclei in replicative stages, very small spores (approximately $1.0$–$1.5\\,\\mu\\text{m}$) with an inconspicuous or absent posterior vacuole; Encephalitozoon develops within a parasitophorous vacuole, shows diplokaryotic nuclei in replicative stages, and has slightly larger spores (approximately $1.5$–$2.5\\,\\mu\\text{m}$) with a distinct posterior vacuole. Thus, the intestinal isolate is Enterocytozoon and the conjunctival isolate is Encephalitozoon.\n\nB. Enterocytozoon is defined by obligatory development inside a parasitophorous vacuole with diplokaryotic nuclei and larger spores (greater than $2.0\\,\\mu\\text{m}$) with a prominent posterior vacuole; Encephalitozoon develops freely in the cytoplasm with monokaryotic nuclei and smaller spores (less than $1.5\\,\\mu\\text{m}$). Thus, the intestinal isolate is Encephalitozoon and the conjunctival isolate is Enterocytozoon.\n\nC. Enterocytozoon and Encephalitozoon are most reliably differentiated by acid-fast staining patterns and the presence of oocysts; Enterocytozoon forms acid-fast oocysts with extracytoplasmic development, whereas Encephalitozoon forms non–acid-fast oocysts within host mitochondria. Thus, the intestinal isolate is Enterocytozoon and the conjunctival isolate is Encephalitozoon.\n\nD. The only reliable discriminator is polar tube coil count: Enterocytozoon has more than $20$ coils arranged in multiple rows, whereas Encephalitozoon has fewer than $5$ coils. Spore size, nuclear arrangement, and host cell localization are variable and not useful. Therefore, the intestinal isolate is Enterocytozoon and the conjunctival isolate is Encephalitozoon.", "solution": "### Problem Validation\n\n**Step 1: Extract Givens**\n\nThe problem provides the following information:\n\n**Foundational Base Principles:**\n1.  Microsporidia are obligate intracellular, spore-forming fungal parasites.\n2.  Infection occurs via injection of sporoplasm from a polar tube.\n3.  Development occurs either freely in the host cytoplasm or within a host-derived parasitophorous vacuole (PV). The presence/absence of a PV is a key ultrastructural feature.\n4.  Mature spores possess an exospore, endospore, polaroplast, polar tube, and often a posterior vacuole.\n5.  The nuclear arrangement during replication is either monokaryotic (single nucleus) or diplokaryotic (paired nuclei) and is a genus-level characteristic.\n\n**Clinical Isolate 1 (Intestinal):**\n*   **Presentation:** Immunocompromised adult, chronic watery diarrhea.\n*   **Specimen:** Stool concentrate and biopsied jejunal mucosa.\n*   **Microscopy (General):** Oval spores, distinct anterior dense zone, faint posterior clear zone.\n*   **Ultrastructure (TEM):**\n    *   Intracellular development within enterocytes.\n    *   Replicative stages are in **direct contact with host cytoplasm** (no PV).\n    *   Nuclei are **singly** observed (**monokaryotic**).\n    *   Mature spore length is approximately **$1.2\\,\\mu\\text{m}$**.\n    *   **Thin** endospore.\n    *   **Inconspicuous** posterior vacuole.\n\n**Clinical Isolate 2 (Conjunctival):**\n*   **Presentation:** Immunocompromised patient.\n*   **Specimen:** Conjunctival scraping.\n*   **Ultrastructure (TEM):**\n    *   Intracellular organisms are **confined within a host-derived parasitophorous vacuole (PV)**.\n    *   Replicative stages show **paired nuclei** (**diplokaryotic**).\n    *   Mature spore length is approximately **$2.0\\,\\mu\\text{m}$**.\n    *   **Thicker** endospore.\n    *   **Distinct** posterior vacuole.\n\n**Task:**\n*   Derive criteria to distinguish the genera *Enterocytozoon* and *Encephalitozoon*.\n*   Classify the two clinical isolates.\n\n**Step 2: Validate Using Extracted Givens**\n\n1.  **Scientifically Grounded:** The problem statement is firmly rooted in established principles of medical parasitology. The descriptions of microsporidian biology, life cycle stages (merogony, sporogony), and key morphological features (PV, nuclear arrangement, spore size) are accurate. The clinical presentations described for the two isolates are classic manifestations of infections with *Enterocytozoon bieneusi* and *Encephalitozoon* species, respectively. The data provided are factually correct and consistent with current scientific understanding.\n2.  **Well-Posed:** The problem is well-posed. It provides sufficient, non-contradictory information in the form of two detailed case studies and a set of foundational principles. The task is clearly defined: to derive distinguishing criteria and apply them. This structure allows for a unique and logical solution.\n3.  **Objective:** The language used is clinical, descriptive, and objective. Terms like \"direct contact with host cytoplasm,\" \"monokaryotic,\" \"diplokaryotic,\" and spore measurements are precise and standard in ultrastructural pathology and biology, free from subjective bias.\n4.  **Completeness and Consistency:** The problem is self-contained and internally consistent. The features described for each isolate form a coherent biological profile, and these profiles are distinct from one another, allowing for a comparative analysis as requested. There is no missing or contradictory information.\n5.  **Feasibility:** The described scenarios are realistic. Microsporidiosis is a known opportunistic infection in immunocompromised individuals. The described spore dimensions and ultrastructural features are within the accepted ranges for the most common human-pathogenic microsporidia.\n\n**Step 3: Verdict and Action**\n\nThe problem statement is **valid**. It is scientifically sound, objective, well-posed, and contains sufficient information to proceed to a full solution.\n\n### Solution Derivation\n\nThe task requires us to use the provided foundational principles and descriptive data to derive a set of distinguishing criteria for the genera *Enterocytozoon* and *Encephalitozoon*, and then to classify the two isolates.\n\n**Derivation of Criteria:**\nBased on established parasitological knowledge, which is correctly summarized in the problem's foundational base, the primary features for differentiating major human-pathogenic microsporidian genera are the host-parasite interface (presence or absence of a parasitophorous vacuole, PV) and the nuclear arrangement during replication. Spore morphology, including size and the nature of the posterior vacuole, provides confirmatory evidence.\n\nWe can organize the given information for the two isolates into a comparative table:\n\n| Feature                     | Isolate 1 (Intestinal)           | Isolate 2 (Conjunctival)              |\n|-----------------------------|----------------------------------|---------------------------------------|\n| Host-Parasite Interface     | Direct contact with cytoplasm (No PV) | Within a parasitophorous vacuole (PV) |\n| Nuclear Arrangement         | Monokaryotic                     | Diplokaryotic                         |\n| Spore Size (Length)         | approx. $1.2\\,\\mu\\text{m}$       | approx. $2.0\\,\\mu\\text{m}$            |\n| Posterior Vacuole           | Inconspicuous                    | Distinct                              |\n\nFrom these observations and foundational principles, we can establish the characteristics of the two genera in question:\n1.  **Genus characterized by Isolate 1's profile:** Development in direct contact with host cytoplasm (no PV), monokaryotic replicative stages, and small spores (approx. $1.2\\,\\mu\\text{m}$). In medical parasitology, this unique combination of features is the definitive profile for the genus *Enterocytozoon* (specifically the species *Enterocytozoon bieneusi*).\n2.  **Genus characterized by Isolate 2's profile:** Development within a well-defined PV, diplokaryotic replicative stages, and slightly larger spores (approx. $2.0\\,\\mu\\text{m}$). This profile is characteristic of the genus *Encephalitozoon* (which includes species like *E. intestinalis*, *E. hellem*, and *E. cuniculi*).\n\nTherefore, the derived criteria set is:\n*   ***Enterocytozoon***: No PV (direct cytoplasmic development), monokaryotic state, spores approx. $1.0$–$1.5\\,\\mu\\text{m}$.\n*   ***Encephalitozoon***: PV present, diplokaryotic state, spores approx. $1.5$–$2.5\\,\\mu\\text{m}$.\n\n**Classification of Isolates:**\n*   **Isolate 1 (Intestinal)**, with its lack of a PV, monokaryotic nuclei, and small spores ($1.2\\,\\mu\\text{m}$), is correctly identified as **_Enterocytozoon_**.\n*   **Isolate 2 (Conjunctival)**, with its development within a PV, diplokaryotic nuclei, and larger spores ($2.0\\,\\mu\\text{m}$), is correctly identified as **_Encephalitozoon_**.\n\n### Option-by-Option Analysis\n\n**A. Enterocytozoon is characterized by direct cytoplasmic development without a parasitophorous vacuole, monokaryotic nuclei in replicative stages, very small spores (approximately $1.0$–$1.5\\,\\mu\\text{m}$) with an inconspicuous or absent posterior vacuole; Encephalitozoon develops within a parasitophorous vacuole, shows diplokaryotic nuclei in replicative stages, and has slightly larger spores (approximately $1.5$–$2.5\\,\\mu\\text{m}$) with a distinct posterior vacuole. Thus, the intestinal isolate is Enterocytozoon and the conjunctival isolate is Encephalitozoon.**\n*   **Evaluation:** This option accurately states the key distinguishing criteria derived from established principles. The description of *Enterocytozoon* matches the characteristics of Isolate 1. The description of *Encephalitozoon* matches the characteristics of Isolate 2. The subsequent classification of the isolates is therefore correct and logically follows from the accurate premise.\n*   **Verdict:** **Correct**.\n\n**B. Enterocytozoon is defined by obligatory development inside a parasitophorous vacuole with diplokaryotic nuclei and larger spores (greater than $2.0\\,\\mu\\text{m}$) with a prominent posterior vacuole; Encephalitozoon develops freely in the cytoplasm with monokaryotic nuclei and smaller spores (less than $1.5\\,\\mu\\text{m}$). Thus, the intestinal isolate is Encephalitozoon and the conjunctival isolate is Enterocytozoon.**\n*   **Evaluation:** This option incorrectly swaps the defining characteristics of the two genera. *Enterocytozoon* develops without a PV, while *Encephalitozoon* develops within one. The nuclear arrangement and typical spore sizes are also inverted. Consequently, the classification is incorrect.\n*   **Verdict:** **Incorrect**.\n\n**C. Enterocytozoon and Encephalitozoon are most reliably differentiated by acid-fast staining patterns and the presence of oocysts; Enterocytozoon forms acid-fast oocysts with extracytoplasmic development, whereas Encephalitozoon forms non–acid-fast oocysts within host mitochondria. Thus, the intestinal isolate is Enterocytozoon and the conjunctival isolate is Encephalitozoon.**\n*   **Evaluation:** This option contains multiple fundamental errors. Microsporidia produce **spores**, not oocysts; oocysts are characteristic of Apicomplexan parasites like *Cryptosporidium*. Both genera are obligate **intracellular** parasites, so \"extracytoplasmic development\" is incorrect. Neither genus develops within host mitochondria. The entire premise for differentiation is factually incorrect and conflates microsporidia with other organisms.\n*   **Verdict:** **Incorrect**.\n\n**D. The only reliable discriminator is polar tube coil count: Enterocytozoon has more than $20$ coils arranged in multiple rows, whereas Encephalitozoon has fewer than $5$ coils. Spore size, nuclear arrangement, and host cell localization are variable and not useful. Therefore, the intestinal isolate is Enterocytozoon and the conjunctival isolate is Encephalitozoon.**\n*   **Evaluation:** This option is incorrect on two counts. First, it dismisses spore size, nuclear arrangement, and host cell localization as \"not useful,\" which is factually wrong; these are primary, genus-level taxonomic characters. Second, the information about polar tube coils is incorrect. *Enterocytozoon bieneusi* has a small number of coils ($5$–$7$) in a single row, not more than $20$. While the final classification happens to be correct, the reasoning provided is entirely false. A conclusion derived from false premises is scientifically invalid.\n*   **Verdict:** **Incorrect**.", "answer": "$$\\boxed{A}$$", "id": "4801740"}, {"introduction": "Beyond identifying a parasite, a clinician must critically interpret the results of diagnostic tests. This exercise delves into the statistical principles behind a hypothetical molecular assay for microsporidia, demonstrating how to derive and calculate its Positive Predictive Value (PPV). This practice is crucial for understanding that a test's real-world utility is shaped not just by its sensitivity and specificity, but also by the disease prevalence within the tested population [@problem_id:4801725].", "problem": "A clinical parasitology laboratory evaluates a Polymerase Chain Reaction (PCR) assay for detecting intestinal microsporidia in immunocompromised patients with chronic diarrhea. Let $D$ denote the event that a patient truly has microsporidiosis and $T^{+}$ denote a positive PCR result. Assume that the prevalence of microsporidiosis in the tested cohort is $0.10$, the assay sensitivity is $0.95$, and the assay specificity is $0.98$. Using only foundational probabilistic definitions and the law of conditional probability, proceed as follows:\n\n1. Define sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) in terms of conditional probabilities $P(\\cdot)$ involving $D$, $\\neg D$, $T^{+}$, and $T^{-}$.\n2. Starting from first principles, derive a closed-form expression for $P(D \\mid T^{+})$ in terms of $P(T^{+} \\mid D)$, $P(T^{-} \\mid \\neg D)$, and $P(D)$.\n3. Use the given sensitivity $0.95$ for $P(T^{+} \\mid D)$, specificity $0.98$ for $P(T^{-} \\mid \\neg D)$, and prevalence $0.10$ for $P(D)$ to compute the positive predictive value. Express your final PPV as a decimal and round your answer to four significant figures.", "solution": "The problem statement has been evaluated and is deemed valid. It is scientifically grounded in the principles of probability theory and its application to medical diagnostics, specifically epidemiology. The problem is well-posed, providing all necessary information—prevalence, sensitivity, and specificity—to uniquely determine the positive predictive value. The terminology is precise and objective, and the requested values are realistic for a clinical setting.\n\nThe problem is addressed in three parts as requested.\n\n### Part 1: Definitions of Diagnostic Test Metrics\n\nLet $D$ be the event that a patient has the disease (microsporidiosis), and let $\\neg D$ be the event that the patient does not have the disease. Let $T^{+}$ be the event of a positive test result, and $T^{-}$ be the event of a negative test result. The key performance metrics of a diagnostic test are defined as conditional probabilities:\n\n1.  **Sensitivity**: The probability of a positive test result given that the patient has the disease. This is the true positive rate.\n    $$ \\text{Sensitivity} = P(T^{+} \\mid D) $$\n\n2.  **Specificity**: The probability of a negative test result given that the patient does not have the disease. This is the true negative rate.\n    $$ \\text{Specificity} = P(T^{-} \\mid \\neg D) $$\n\n3.  **Positive Predictive Value (PPV)**: The probability that a patient with a positive test result actually has the disease.\n    $$ \\text{PPV} = P(D \\mid T^{+}) $$\n\n4.  **Negative Predictive Value (NPV)**: The probability that a patient with a negative test result actually does not have the disease.\n    $$ \\text{NPV} = P(\\neg D \\mid T^{-}) $$\n\n### Part 2: Derivation of the Positive Predictive Value (PPV)\n\nWe are asked to derive a closed-form expression for $P(D \\mid T^{+})$ (the PPV) in terms of $P(T^{+} \\mid D)$ (sensitivity), $P(T^{-} \\mid \\neg D)$ (specificity), and $P(D)$ (prevalence). The derivation proceeds from the foundational definition of conditional probability, which states that for any two events $A$ and $B$, $P(A \\mid B) = \\frac{P(A \\cap B)}{P(B)}$.\n\nApplying this definition to $P(D \\mid T^{+})$, we have:\n$$ P(D \\mid T^{+}) = \\frac{P(D \\cap T^{+})}{P(T^{+})} $$\n\nThe numerator, $P(D \\cap T^{+})$, is the joint probability of having the disease and testing positive. It can be re-expressed using the definition of conditional probability:\n$$ P(D \\cap T^{+}) = P(T^{+} \\mid D) P(D) $$\n\nThe denominator, $P(T^{+})$, is the total probability of obtaining a positive test result. A positive result can occur in two mutually exclusive scenarios: a true positive (the patient has the disease and tests positive, $D \\cap T^{+}$) or a false positive (the patient does not have the disease but tests positive, $\\neg D \\cap T^{+}$). By the Law of Total Probability, we can write $P(T^{+})$ as the sum of the probabilities of these two events:\n$$ P(T^{+}) = P(D \\cap T^{+}) + P(\\neg D \\cap T^{+}) $$\n\nUsing the definition of conditional probability for each term in the sum:\n$$ P(T^{+}) = P(T^{+} \\mid D) P(D) + P(T^{+} \\mid \\neg D) P(\\neg D) $$\n\nThe problem provides specificity, $P(T^{-} \\mid \\neg D)$, but we need $P(T^{+} \\mid \\neg D)$. For a patient without the disease ($\\neg D$), the test can only be positive ($T^{+}$) or negative ($T^{-}$). Thus, the sum of their probabilities is $1$:\n$$ P(T^{+} \\mid \\neg D) + P(T^{-} \\mid \\neg D) = 1 $$\nThis allows us to express the false positive rate in terms of specificity:\n$$ P(T^{+} \\mid \\neg D) = 1 - P(T^{-} \\mid \\neg D) $$\n\nSimilarly, the probability of not having the disease, $P(\\neg D)$, is the complement of the prevalence, $P(D)$:\n$$ P(\\neg D) = 1 - P(D) $$\n\nSubstituting these expressions back into the equation for $P(T^{+})$:\n$$ P(T^{+}) = P(T^{+} \\mid D) P(D) + \\left(1 - P(T^{-} \\mid \\neg D)\\right) \\left(1 - P(D)\\right) $$\n\nFinally, assembling the full expression for $P(D \\mid T^{+})$ by substituting the expanded forms for the numerator and denominator gives the desired result, which is an expression of Bayes' Theorem:\n$$ P(D \\mid T^{+}) = \\frac{P(T^{+} \\mid D) P(D)}{P(T^{+} \\mid D) P(D) + \\left(1 - P(T^{-} \\mid \\neg D)\\right) \\left(1 - P(D)\\right)} $$\nThis formula expresses the PPV, $P(D \\mid T^{+})$, solely in terms of sensitivity ($P(T^{+} \\mid D)$), specificity ($P(T^{-} \\mid \\neg D)$), and prevalence ($P(D)$).\n\n### Part 3: Calculation of the PPV\n\nWe are given the following values:\n- Prevalence, $P(D) = 0.10$\n- Sensitivity, $P(T^{+} \\mid D) = 0.95$\n- Specificity, $P(T^{-} \\mid \\neg D) = 0.98$\n\nWe also need the complements:\n- $P(\\neg D) = 1 - P(D) = 1 - 0.10 = 0.90$\n- The false positive rate, $P(T^{+} \\mid \\neg D) = 1 - P(T^{-} \\mid \\neg D) = 1 - 0.98 = 0.02$\n\nNow, we substitute these numerical values into the derived formula for the PPV:\n$$ P(D \\mid T^{+}) = \\frac{P(T^{+} \\mid D) P(D)}{P(T^{+} \\mid D) P(D) + P(T^{+} \\mid \\neg D) P(\\neg D)} $$\n$$ P(D \\mid T^{+}) = \\frac{(0.95)(0.10)}{(0.95)(0.10) + (0.02)(0.90)} $$\n\nCalculate the numerator and the two terms in the denominator:\n- Numerator (True Positives): $0.95 \\times 0.10 = 0.095$\n- Denominator Term 1 (True Positives): $0.95 \\times 0.10 = 0.095$\n- Denominator Term 2 (False Positives): $0.02 \\times 0.90 = 0.018$\n\nSubstitute these intermediate results back into the equation:\n$$ P(D \\mid T^{+}) = \\frac{0.095}{0.095 + 0.018} $$\n$$ P(D \\mid T^{+}) = \\frac{0.095}{0.113} $$\n\nPerforming the final division:\n$$ P(D \\mid T^{+}) \\approx 0.8407079646... $$\n\nRounding the result to four significant figures as requested gives $0.8407$. This is the positive predictive value of the assay for this patient cohort.", "answer": "$$\\boxed{0.8407}$$", "id": "4801725"}, {"introduction": "To control the spread of infections, we must understand how they are transmitted. This problem places you in the role of an epidemiologist investigating a potential outbreak, using data from a hypothetical survey to quantify the link between an environmental exposure and microsporidiosis. By calculating the odds ratio and its confidence interval, you will learn a core skill for identifying risk factors, providing the evidence base for public health interventions aimed at protecting vulnerable populations [@problem_id:4801718].", "problem": "A cross-sectional survey of immunocompromised adults with Human Immunodeficiency Virus (HIV) infection was conducted at a tertiary care hospital to investigate environmental risk factors for microsporidiosis, an opportunistic intestinal infection caused by obligate intracellular spore-forming parasites of the phylum Microsporidia. Stool diagnosis was performed using a modified trichrome stain and confirmed by Polymerase Chain Reaction (PCR). Exposure was defined as routine consumption of unboiled tap water at home over the prior $4$ weeks, assessed by a structured questionnaire. The resulting $2 \\times 2$ count data were as follows: among microsporidiosis-positive patients ($n = 60$), $45$ reported consuming unboiled tap water and $15$ did not; among microsporidiosis-negative patients ($n = 200$), $80$ reported consuming unboiled tap water and $120$ did not.\n\nStarting only from core definitions and widely used large-sample principles in epidemiology and biostatistics—namely: the definition of odds as $p/(1-p)$ for a probability $p$, the definition of the odds ratio as the ratio of two odds, and asymptotic normality of smooth estimators under standard regularity conditions—perform the following:\n\n1. From first principles, derive the sample odds ratio for the association between unboiled tap water consumption (exposed) and microsporidiosis status (diseased) in this case-control table.\n2. Using appropriate asymptotic reasoning, derive a $95\\%$ confidence interval for the true odds ratio based on these counts, making your steps explicit, including any variance approximations you invoke and how they arise from the definitions.\n3. Provide a concise interpretation of the point estimate and the confidence interval in the context of transmission of microsporidia via drinking water in immunocompromised hosts.\n\nReport the odds ratio as your final numerical answer, rounded to three significant figures. Do not include any units in your final answer. The confidence interval and interpretation should be clearly presented in your working, but only the odds ratio itself should be reported as the final numerical answer.", "solution": "The problem is first subjected to validation.\n\n### Step 1: Extract Givens\n\nThe data and definitions provided are:\n- Study type: Cross-sectional survey of immunocompromised adults with HIV.\n- Outcome: Microsporidiosis status (positive or negative).\n- Exposure: Consumption of unboiled tap water over the prior $4$ weeks.\n- The data are presented in a $2 \\times 2$ table format:\n  - Total microsporidiosis-positive patients: $60$.\n    - Number exposed (consumed unboiled tap water): $45$. Let this be $a$.\n    - Number unexposed (did not consume): $15$. Let this be $c$.\n  - Total microsporidiosis-negative patients: $200$.\n    - Number exposed (consumed unboiled tap water): $80$. Let this be $b$.\n    - Number unexposed (did not consume): $120$. Let this be $d$.\n- Core definitions to be used:\n  - Odds for a probability $p$ is defined as $p/(1-p)$.\n  - Odds ratio is the ratio of two odds.\n  - The solution must rely on asymptotic normality of estimators.\n- Tasks:\n  1. Derive the sample odds ratio.\n  2. Derive a $95\\%$ confidence interval for the true odds ratio.\n  3. Interpret the point estimate and confidence interval.\n- Final answer requirement: The odds ratio rounded to three significant figures.\n\n### Step 2: Validate Using Extracted Givens\n\nThe problem is assessed for validity:\n- **Scientifically Grounded:** The problem is sound. It describes a standard epidemiological study design (cross-sectional, analyzed as a case-control study) to investigate a plausible risk factor (waterborne transmission) for a known opportunistic infection (microsporidiosis) in a relevant population (immunocompromised patients). The statistical methods requested are standard in biostatistics.\n- **Well-Posed:** The problem is well-posed. All necessary data are provided in a consistent format ($a+c = 45+15=60$ and $b+d = 80+120=200$). The objectives are clearly stated. A unique, meaningful solution can be determined.\n- **Objective:** The problem is stated in objective, scientific language, free of bias or subjective claims.\n\n### Step 3: Verdict and Action\n\nThe problem is deemed **valid** as it is scientifically grounded, well-posed, and objective. It contains no invalidating flaws. The solution proceeds.\n\n### Solution Derivation\n\nThe analysis is based on the provided $2 \\times 2$ contingency table, where rows represent exposure status and columns represent disease status.\n\n| | Diseased ($D=1$) | Not Diseased ($D=0$) |\n| :--- | :---: | :---: |\n| **Exposed ($E=1$)** | $a = 45$ | $b = 80$ |\n| **Unexposed ($E=0$)** | $c = 15$ | $d = 120$ |\n| **Total** | $n_1 = 60$| $n_0 = 200$|\n\n#### 1. Derivation of the Sample Odds Ratio\n\nThe odds ratio ($OR$) in this context compares the odds of exposure among the diseased (cases) to the odds of exposure among the non-diseased (controls).\n\nLet $p_1 = P(E=1|D=1)$ be the probability of being exposed given that one is diseased. The sample estimate for this probability is $\\hat{p}_1 = \\frac{a}{a+c}$.\nThe odds of exposure among the diseased is defined as $\\frac{p_1}{1-p_1}$. The sample estimate of these odds is:\n$$ \\text{Odds}_{\\text{cases}} = \\frac{\\hat{p}_1}{1-\\hat{p}_1} = \\frac{\\frac{a}{a+c}}{1 - \\frac{a}{a+c}} = \\frac{\\frac{a}{a+c}}{\\frac{c}{a+c}} = \\frac{a}{c} $$\n\nLet $p_0 = P(E=1|D=0)$ be the probability of being exposed given that one is not diseased. The sample estimate for this probability is $\\hat{p}_0 = \\frac{b}{b+d}$.\nThe odds of exposure among the non-diseased is defined as $\\frac{p_0}{1-p_0}$. The sample estimate of these odds is:\n$$ \\text{Odds}_{\\text{controls}} = \\frac{\\hat{p}_0}{1-\\hat{p}_0} = \\frac{\\frac{b}{b+d}}{1 - \\frac{b}{b+d}} = \\frac{\\frac{b}{b+d}}{\\frac{d}{b+d}} = \\frac{b}{d} $$\n\nThe sample odds ratio, $\\widehat{OR}$, is the ratio of these two estimated odds, derived from first principles as requested:\n$$ \\widehat{OR} = \\frac{\\text{Odds}_{\\text{cases}}}{\\text{Odds}_{\\text{controls}}} = \\frac{a/c}{b/d} = \\frac{ad}{bc} $$\n\nSubstituting the given values:\n$$ \\widehat{OR} = \\frac{45 \\times 120}{80 \\times 15} = \\frac{5400}{1200} = 4.5 $$\n\n#### 2. Derivation of the 95% Confidence Interval\n\nThe distribution of the sample odds ratio, $\\widehat{OR}$, is typically skewed. However, based on the principle of asymptotic normality for smooth estimators, the distribution of the natural logarithm of the odds ratio, $\\ln(\\widehat{OR})$, converges to a normal distribution more rapidly. We therefore construct a confidence interval on the log scale and then transform it back.\n\nLet $\\theta = \\ln(OR)$ be the true log-odds ratio. The sample estimate is $\\hat{\\theta} = \\ln(\\widehat{OR})$.\n$$ \\hat{\\theta} = \\ln\\left(\\frac{ad}{bc}\\right) = \\ln(a) + \\ln(d) - \\ln(b) - \\ln(c) $$\n\nTo find the confidence interval, we need the variance of $\\hat{\\theta}$. Under the assumption of large sample sizes, the cell counts $a$, $b$, $c$, and $d$ can be treated as independent Poisson-distributed variables. For a Poisson variable $X$ with mean $\\lambda$, the variance of $\\ln(X)$ is approximately $1/\\lambda$. Estimating $\\lambda$ with the observed count, we have $Var(\\ln(X)) \\approx 1/X$. Since the log-odds ratio estimate is a linear combination of the logs of the cell counts, its variance is the sum of the individual variances (an application of the delta method):\n$$ Var(\\hat{\\theta}) = Var(\\ln(\\widehat{OR})) \\approx Var(\\ln(a)) + Var(\\ln(d)) + Var(\\ln(b)) + Var(\\ln(c)) $$\n$$ \\widehat{Var}(\\ln(\\widehat{OR})) = \\frac{1}{a} + \\frac{1}{b} + \\frac{1}{c} + \\frac{1}{d} $$\nThis approximation is known as the Woolf standard error.\n\nThe standard error of the log-odds ratio is the square root of its variance:\n$$ SE(\\ln(\\widehat{OR})) = \\sqrt{\\frac{1}{a} + \\frac{1}{b} + \\frac{1}{c} + \\frac{1}{d}} $$\n\nSubstituting the values from the problem:\n$$ SE(\\ln(\\widehat{OR})) = \\sqrt{\\frac{1}{45} + \\frac{1}{80} + \\frac{1}{15} + \\frac{1}{120}} \\approx \\sqrt{0.02222... + 0.0125 + 0.06666... + 0.00833...} $$\n$$ SE(\\ln(\\widehat{OR})) \\approx \\sqrt{0.109722...} \\approx 0.33124 $$\n\nA $95\\%$ confidence interval for the true log-odds ratio, $\\theta$, is constructed using the normal approximation:\n$$ CI_{95\\%}(\\theta) = \\hat{\\theta} \\pm z_{1-\\alpha/2} \\times SE(\\hat{\\theta}) $$\nFor a $95\\%$ CI, $\\alpha=0.05$, and the critical value from the standard normal distribution is $z_{0.975} \\approx 1.96$.\nThe estimated log-odds ratio is $\\hat{\\theta} = \\ln(4.5) \\approx 1.5041$.\n\nThe $95\\%$ CI for $\\ln(OR)$ is:\n$$ 1.5041 \\pm 1.96 \\times 0.33124 $$\n$$ 1.5041 \\pm 0.6492 $$\nThe lower bound is $1.5041 - 0.6492 = 0.8549$.\nThe upper bound is $1.5041 + 0.6492 = 2.1533$.\n\nTo obtain the confidence interval for the odds ratio itself, we exponentiate the lower and upper bounds of the interval for the log-odds ratio:\n$$ CI_{95\\%}(OR) = [\\exp(0.8549), \\exp(2.1533)] $$\n$$ CI_{95\\%}(OR) \\approx [2.35, 8.61] $$\n\n#### 3. Interpretation of Results\n\n- **Point Estimate ($\\widehat{OR} = 4.5$):** In this sample of immunocompromised adults, the odds of having consumed unboiled tap water were $4.5$ times higher among individuals with microsporidiosis than among those without microsporidiosis. This indicates a strong positive association between the specified exposure and the disease.\n\n- **Confidence Interval ($95\\%$ CI: $[2.35, 8.61]$):** We are $95\\%$ confident that the interval from $2.35$ to $8.61$ contains the true population odds ratio. Since the entire interval lies above $1$, the association is statistically significant at the $\\alpha=0.05$ level. This means it is highly unlikely that the observed association is due to random chance alone. The results provide strong evidence supporting the hypothesis that consumption of unboiled tap water is a risk factor for microsporidiosis in this population. The width of the interval reflects the precision of the estimate; a narrower interval would suggest a more precise estimate.\n\nThe final answer requires only the numerical odds ratio, rounded to three significant figures.\n$4.5$ is correctly written as $4.50$ to three significant figures.", "answer": "$$\\boxed{4.50}$$", "id": "4801718"}]}